Features rulemaking activity by DOL, DHS, FWS, EPA, and FCC.
With opinions and analysis from Bridget Dooling, Scott Sumner, Zhoudan Xie, James Pethokoukis, Mark Febrizio, Jennifer Huddleston, Benjamin Zycher, Andrea O'Sullivan, James Broughel, and Ewelina Czapla.
Plus news from The Hill, NBC, New York Times, Wall Street Journal, Bloomberg, Washington Post, CNBC, Reuters, E&E News, and Associated Press.
Dr. Roslyn Layton
Visiting Scholar
American Enterprise Institute
"The Regulation Digest is better than an algorithm."
Adam J. White
Executive Director
Center for the Study of the Administrative State
"I recommend everyone subscribe to the Regulation Digest. It's really indispensable."
Features rulemaking activity related to COVID-19 from APHIS, DARS, ED, EOP, CDC, FDA & FEMA; plus other notable actions from EPA, DOL, DHS, & APHIS.
With opinions and analysis from Susan Dudley, Sally Katzen, Cass Sunstein, Jerry Ellig, Stuart Shaprio, Andrew Wheeler, Babette Boliek, Roslyn Layton, Wayne Crews, Robert Graboyes, Dan Bosch, Alan Krupnick, Christopher Walker, James Broughel, Elle Rothermich, Randy May, and others.
Plus news from The Hill, NBC, New York Times, Wall Street Journal, Washington Post, CBS, Reuters, E&E News, and Associated Press.
Features rulemaking activity related to COVID-19 from ED, HHS, NIH, DHS, FEMA, NCUA, & FAA; plus other notable actions from EPA, OPM, DHS, DEA, FWS, EPA, FHFA & FinCEN.
With opinions and analysis from Susan Dudley, Daniel Pérez, Cass Sunstein, Douglas Holtz-Eakin, William Yeatman, Ike Brannon, Bill Zeiser, Elise Amez-Droz, Jonathan Adler, Holman Jenkins, Kimberly Strassel, Heidi Shierholz, Dan Bosch, Ido Sivan-Sevilla, and others.
Plus news from The Hill, New York Times, Wall Street Journal, Washington Post, E&E News and Associated Press.
Features rulemaking activity related to COVID-19 from HUD, HRSA, and the EOP; plus other notable actions from DOL, EOIR, DOJ, FAA, FWS, NOAA, IRS, SEC, DOT, and DOE.
With opinions and analysis from Susan Dudley, Daniel Pérez, Jerry Ellig, Cass Sunstein, Ilya Somin, Rachel Augustine Potter, David Boaz, Matt Perault, James Broughel, Stuart Shapiro, Eugene Volokh, Jennifer Huddleston, Eugene Scalia, Shoshana Weissmann, Ed Glaeser, and others.
Plus news from The Hill, New York Times, Wall Street Journal, Washington Post, and NPR.
Features rulemaking activity related to COVID-19 from CDC, FDA, FEMA and VA; plus other notable actions from EPA, NHTSA, DOI, DOE, and FCC.
With opinions and analysis from Susan Dudley, Richard Pierce, Jerry Ellig, Cass Sunstein, Veronique de Rugy, Joseph Postell, Brent Skorup, James Broughel, Kofi Ampaabeng, Megan McArdle, Randolph May, Maggie Siddiqi, David Coursen, and others.
Plus news from Government Executive, New York Times, Wall Street Journal, Reuters, CNN, Forbes, and Space News.
Features rulemaking activity related to COVID-19 from HHS, CDC, FDA, and USCBP; plus other notable actions from CMS, HHS, FCC, DOT, DOJ, and CPSC.
With opinions and analysis from Susan Dudley, Donald Boudreaux, Peter Wallison, Richard Revesz, Rachel Sachs, Todd Phillips, Jessica Melugin, William Funk, Alex Nowrasteh, William Yeatman, Doug Badger, Elizabeth Nolan Brown, and Christopher Walker.
Plus news from Government Executive, New York Times, Wall Street Journal, Reuters, NPR, Bloomberg, and The Hill.
Features rulemaking activity related to COVID-19 from IRS, FDA, HHS, and FEMA; plus other notable actions from DHS, FTC, EPA, CMS, and DOL.
With opinions and analysis from Susan Dudley, Cass Sunstein, Robert Graboyes, Richard Pierce, Christopher Walker, Elizabeth Nolan Brown, Connor Raso, Richard Revesz, Jayni Hein, and Senator Mike Lee.
Plus news from NBC News, Federal News Network, New York Times, Wall Street Journal, Reuters, Politico, Bloomberg, and The Hill.
Features rulemaking activity related to COVID-19 from ED and IRS; plus other notable actions from CFPB, EPA, IRS, and DHS.
With opinions and analysis from Susan Dudley, Cass Sunstein, Michael Farren, Craig Keats, Allison Schrager, Richard Pierece, James Broughel, Shane Tews, and Wayne Crews.
Plus news from Government Executive, Federal News Network, New York Times, Wall Street Journal, Politico, Associated Press, and The Hill.
Features rulemaking activity related to COVID-19 from USDA, CDC, NIH, HHS, and DOD, plus other notable actions by DHS, DOE, DEA, FRA, NHTSA, and EPA.
With opinions and analysis from Jerry Ellig, Hamilton Cota Cruz, Mark Febrizio, Bethany Davis Noll, Jonathan Adler, Cass Sunstein, Natasha Sarin, Casey Mulligan, Ian Jefferies, and Karen Palmer.
Plus news from Government Executive, Bloomberg, Vox, Wall Street Journal, Business Insider, and New York Times.
Features rulemaking activity related to COVID-19 from USAID and CBP; plus other notable actions from FinCEN, NOAA, FCC, and CFPB.
With opinions and analysis from Jerry Brock, James Peoples, Michael Farren, Mary Anastasia O'Grady, Peter Boettke, Jennifer Hudleston, Jerry Ellig, Annie Duke, Cass Sunstein, and Evan Kwerel.
Plus news from Politico, Reuters, New York Times, Wall Street Journal, NPR, Associated Press, and The Hill.
This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.
There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.
Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street Journal, New York Times, The Hill, Bloomberg, Forbes, Politico, Reuters, Audubon Magazine, Government Executive, and Law360.
This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.
There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.
Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.
This update includes public interest comments to the DEA, DOT, FDA, and USDA from Laura Stanley, John Bertino, and Mark Febrizio.
Academic papers by Susan Dudley, Zhoudan Xie, and Steven Balla, plus articles published by the Brookings Institution and The Regulatory Review. And a four-chapter report based on a co-operative agreement with the USDA.
Plus various commentaries, op-eds, and quotes in popular media outlets, including the Washington Post, The Hill, Bloomberg, Forbes, and CQ Roll Call.
This update includes testimony before the House Financial Services Subcommittee on Oversight and Investigations, and the General Services Administration by Steven Balla.
Academic papers by Bridget Dooling, Jerry Ellig, Chris Carrigan, Mark Febrizio, and Susan Dudley, and public interest comments submitted to the Surface Transportation Board, Council on Environmental Quality, the Office of Management and Budget, and the Federal Deposit Insurance Corporation.
Plus various commentaries, op-eds, and quotes in popular media outlets, including Federal News Network, The Hill, E&E News, Forbes, and Government Executive.
This update includes an announcement about our 10th anniversary at GW, #RegStudies10!
We feature research from our scholars published by Brookings, the Public Administration Review, and the Review of Austrian Economics journal.
There is also a working paper by Chris Carrigan, Jerry Ellig, and Zhoudan Xie, as well as Mark Febrizio and Susan Dudley's Regulators' Budget report with Melinda Warren from the Weidenbaum Center.
Plus various commentaries, op-eds, and quotes in popular media outlets like The Wall Street Journal, The Hill, Bloomberg, Forbes, Government Executive, Law 360, and Health Affairs.
Working papers, public interest comments, and Congressional testimony by Jerry Ellig, Bridget Dooling, Brian Mannix, Susan Dudley, and Joseph Cordes.
Plus five articles posted by the Journal of Benefit-Cost Analysis convened by the GW Regulatory Studies Center, and scholarly quotes in the Wall Street Journal, Federal News Network, Associated Press, and Bloomberg.
